{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:08:42Z","timestamp":1769270922045,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/igc.0b013e3182978328","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T07:46:26Z","timestamp":1371023186000},"page":"1056-1064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Adjuvant Therapy in Stage III Endometrial Cancer"],"prefix":"10.1016","volume":"23","author":[{"given":"Stephanie","family":"Kuku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e3182978328_bb0010","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicenter randomised trial","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1097\/IGC.0b013e3182978328_bb0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0889-8545(05)70233-3","article-title":"Endometrial adenocarcinoma; a primer for the generalist","volume":"28","author":"Hernendez","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1097\/IGC.0b013e3182978328_bb0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0360-3016(01)01566-8","article-title":"Significant pelvic recurrence in high-risk pathologic stage IYIV endometrial cancer patients after chemotherapy alone: implications for adjuvant radiation therapy","volume":"50","author":"Mundt","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/IGC.0b013e3182978328_bb0025","unstructured":"R: R: A Language and Environment for Statistical Computing, R Development Core Team, Vienna, 2010. Available at: http:\/\/www.R-project.org\/, accessed December 3, 2012."},{"key":"10.1097\/IGC.0b013e3182978328_bb0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2006.08.027","article-title":"The prognostic indicators of positive peritoneal cytology and adnexal\/serosal metastasis in stage IIIA endometrial cancer","volume":"104","author":"Havrilesky","year":"2007","journal-title":"Gynaecol Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0035","first-page":"3097","article-title":"Peritoneal cytology and pre-operative serum Ca-125 are independent prognostic indicators of overall survival in advanced endometrial cancer","volume":"23","author":"Santala","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1097\/IGC.0b013e3182978328_bb0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/gyno.2002.6713","article-title":"Assessment of prognostic factors in stage IIIA endometrial cancer","volume":"86","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0045","first-page":"553","article-title":"Surgical stage III endometrial cancer: analysis of treatment outcomes, prognostic factors and failure patterns","volume":"23","author":"Ayhan","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/gyno.2001.6321","article-title":"Stage III endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant chemotherapy","volume":"83","author":"Aoki","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0055","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1002\/1097-0142(19930601)71:11<3697::AID-CNCR2820711137>3.0.CO;2-U","article-title":"Pathologic stage III endometrial carcinoma: prognostic factors and patterns of recurrence","volume":"71","author":"Greven","year":"1993","journal-title":"Cancer"},{"key":"10.1097\/IGC.0b013e3182978328_bb0060","first-page":"553","article-title":"Surgical stage III endometrial cancer; analysis of treatment outcomes, prognostic factors and failure patterns","volume":"23","author":"Ayhan","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0065","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ygyno.2004.11.033","article-title":"Lymphovascular space involvement: an independent prognostic factor in endometrial cancer","volume":"96","author":"Briet","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2007.09.029","article-title":"Randomised phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate-and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study","volume":"108","author":"Susumu","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","article-title":"Adjuvant chemotherapy and radiotherapy in high-risk endometrial cancer: results of a randomised trial","volume":"95","author":"Maggi","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1097\/IGC.0b013e3182978328_bb0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomised phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced stage endometrial carcinoma: a Gynaecologic Oncology Group study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0085","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancerVresults from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1097\/IGC.0b013e3182978328_bb0090","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1097\/IGC.0b013e3182978328_bb0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000331677","article-title":"Use of adjuvant therapy in patients with FIGO stage iii endometrial carcinoma: a multicenter retrospective study","volume":"81","author":"Marchetti","year":"2011","journal-title":"Oncology"},{"key":"10.1097\/IGC.0b013e3182978328_bb0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2007.06.014","article-title":"The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer","volume":"107","author":"Secord","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2004.02.008","article-title":"Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients","volume":"93","author":"Bruzzone","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/gyno.1996.0274","article-title":"The effect of postsurgical therapy on stage III endometrial carcinoma","volume":"63","author":"Schorge","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0115","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2007.25.18_suppl.5503","article-title":"A randomized phase III study on adjuvant treatment with radiation (RT) +\/j chemotherapy (CT) in early stage high-risk endometrial cancer (NSGO-EC-9501\/EORTC 55991)","author":"Hogberg","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182978328_bb0120","author":"Creutzberg"},{"key":"10.1097\/IGC.0b013e3182978328_bb0125","doi-asserted-by":"crossref","first-page":"546.e1","DOI":"10.1016\/j.ajog.2007.01.018","article-title":"Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome","volume":"196","author":"Denschlag","year":"2007","journal-title":"Am J Obstet Gynecol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24087474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24087474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:35:42Z","timestamp":1753223742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24087474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1048891X24087474"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e3182978328","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant Therapy in Stage III Endometrial Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e3182978328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}